pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Transforming growth factor-beta (TGF-beta) inhibits cell proliferation by inducing a G1-phase cell cycle arrest. Normal progression through G1 is promoted by the activity of the cyclin-dependent protein kinases CDK4 and CDK6 (ref. 2), which are inhibited by the protein p16INK4. We have isolated a new member of the p16INK4 family, p15INK4B. p15 expression is induced approximately 30-fold in human keratinocytes by treatment with TGF-beta, suggesting that p15 may act as an effector of TGF-beta-mediated cell cycle arrest. The gene encoding p15 is located on chromosome 9 adjacent to the p16 gene at a frequent site of chromosomal abnormality in human tumours (9p21).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to p16INK4A, p15INK4B has been shown to an effector of TGF-β meditated cell cycle arrest by inhibiting CDK4/6 (Hannon and Beach, 1994).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Hannon and Beach, 1994
In the citing paper
“Within months of its discovery, the INK4a (CDKN2A) and the genetically linked INK4b gene (CDKN2B) (36) were implicated in a reverse genetic screen to play tumor suppressive roles in familial melanoma (37).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [36]
Citations
Cites
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Research works printed but not linked: 7
- Bates, S. et al. Oncogene 9, 71–79 (1994).
- Merlo, A., Gabrielson, E., Askin, F. & Sidransky, D. Cancer Res. 54, 640–642 (1994).
- Cheng, J. Q., Jhanwar, S. C., Lu, Y. Y. & Testa, J. R. Cancer Res. 53, 4761–4763 (1993).
- Petty, E. M. et al. Am. J. hum. Genet. 53, 96–104 (1993).
- Moses, H. L. et al. in Cancer Cells (eds Feramisco, J., Ozanne, B. & Stiles, C.) 3, 65–71 (1985).
- Manning, A. M., Williams, A. C., Gamie, S. M. & Paraskeva, C. Oncogene 6, 1471–1476 (1991).
- Rodeck, U. et al. Cancer Res. 54, 575–581 (1994).
Cited by
Items 701–800 of 1,003
Genetic and environmental factors in cutaneous malignant melanoma
Paillerets, B. B., Avril, M., Chompret, A., & Démenais, F. (2002) · Biochimie · doi:10.1016/s0300-9084(01)01360-8 · Cited by 60
Adipose-derived stromal cells inhibit prostate cancer cell proliferation inducing apoptosis
Takahara, K., Ii, M., Inamoto, T., Komura, K., Ibuki, N., Minami, K., Uehara, H., Hirano, H., Nomi, H., Kiyama, S., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.080 · Cited by 65
Dai, M., Al-Odaini, A. A., Arakelian, A., Rabbani, S. A., Ali, S., & Lebrun, J. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3322 · Cited by 71
Overexpression of the TGF-β antagonist Smad7 in endometrial cancer
Dowdy, S. C., Mariani, A., Reinholz, M. M., Keeney, G. L., Spelsberg, T. C., Podratz, K. C., & Janknecht, R. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.10.006 · Cited by 59
Bone morphogenetic protein 3B silencing in non-small-cell lung cancer
Dai, Z., Popkie, A. P., Zhu, W., Timmers, C. D., Raval, A., Tannehill‐Gregg, S. H., Morrison, C. D., Auer, H., Kratzke, R. A., Niehans, G. A., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207441 · Cited by 59
P21(Cip1/WAF1) expression in the mouse testis before and after X irradiation
Beumer, T. L., Roepers‐Gajadien, H. L., Gademan, I. S., Rutgers, D. H., & de Rooij, D. G. (1997) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199707)47:3<265::aid-mrd5>3.0.co;2-j · Cited by 59
Cyclin-Dependent Kinase Inhibitors in Yeast, Animals, and Plants: A Functional Comparison
Clercq, A. D., & Inzé, D. (2006) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230600856685 · Cited by 75
“The first, the Ink4 family, consists of four proteins: p16Ink4a (Serrano et al ., 1993), p15Ink4b (Hannon & Beach, 1994), p18Ink4c (Guan et al ., 1994; Hirai et al ., 1995), and p19Ink4d (Chan et al ., 1995; Hirai et al ., 1995).”
BackgroundGarcía, M. J., Martínez–Delgado, B., Cebrián, A., Martínez, Á., Benitez, J. J., & Rivas, C. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64261-7 · Cited by 59
Santoni‐Rugiu, E., Jensen, M. R., Factor, V. M., & Thorgeirsson, S. S. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65425-9 · Cited by 60
Priming in the brain, an immunologically privileged organ, elicits anti-tumor immunity
Fathallah‐Shaykh, H. M., Gao, W., Cho, M., & Herrera, M. A. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980119)75:2<217::aid-ijc9>3.0.co;2-x · Cited by 36
Gombart, A., Roberta Morosetti, A., Cw, M., Jw, S., & Koeffler, H. (1995) · Blood · doi:10.1182/blood.v86.4.1534.bloodjournal8641534 · Cited by 62
Lee, J., French, B., Morgan, T., & French, S. W. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.09.004 · Cited by 58
“In addition to fibrogenesis, TGF-β has also been shown to be able to arrest the cell cycle in G1 through induction of various cyclin inhibitors (Hannon and Beach, 1994; Polyak et al., 1994).”
BackgroundChen, L., Huang, H., Zhang, W., Ding, F., Fan, Z., & Zeng, Z. (2019) · Medical Science Monitor · doi:10.12659/msm.917058 · Cited by 58
Zhou, Y., Kato, H., Asanoma, K., Kondo, H., Arima, T., Kato, K., Matsuda, T., & Wake, N. (2002) · Genomics · doi:10.1006/geno.2002.6860 · Cited by 63
Fortunel, N. O., Hatzfeld, J., Rosemary, P.-A., Ferraris, C., Monier, M., Haydont, V., Longuet, J., Brethon, B., Lim, B., Castiel, I., et al. (2003) · Journal of Cell Science · doi:10.1242/jcs.00702 · Cited by 69
“In addition to the various effectors regulating TGFβ1-induced cell-cycle arrest in keratinocytes (Hannon and Beach, 1994; Ivarone and Massagué, 1999), it will be interesting to focus on genes whose expression may be linked to the maintenance of the epidermal stem cell pool, such as p21(WAF1/Cip1)…”
BackgroundWang, J. C. C., Chen, W., Nallusamy, S., Chen, C., & Novetsky, A. D. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2001.03319.x · Cited by 63
“The products of these genes specifically inhibit cyclin D/cyclindependent kinase 4 and 6 complex (Serrano et al, 1993; Hannon & Beach, 1994), the upstream regulators in the retinoblastoma (Rb) pathway controlling the G1 to S cell cycle check point (Sherr, 1996).”
BackgroundYamato, K., Koseki, T., Ohguchi, M., Kizaki, M., Ikeda, Y., & Nishihara, T. (1997) · Molecular Endocrinology · doi:10.1210/me.11.8.1044 · Cited by 60
Thullberg, M., Bártek, J., & Lukas, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203579 · Cited by 64
Platz, A., Ringborg, U. K., & Hansson, J. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0149 · Cited by 63
Migration and homeostasis of regulatory T cells in rheumatoid arthritis
Kotschenreuther, K., Yan, S., & Kofler, D. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.947636 · Cited by 67
Genes, pathways, and animal models in primary open-angle glaucoma
Iglesias, A. I., Springelkamp, H., Ramdas, W. D., Klaver, C. C. W., Willemsen, R., & van Duijn, C. M. (2015) · Eye · doi:10.1038/eye.2015.160 · Cited by 59
Rahimi, N., Tremblay, E., McAdam, L. C., Roberts, A. B., & Elliott, B. E. (1998) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-998-0023-z · Cited by 57
Dong, X., Pang, X., Yu, S., Su, Y., Wang, H., Yin, Y., Wang, Y., & Chen, W. (2004) · International Journal of Cancer · doi:10.1002/ijc.20363 · Cited by 57
Vijayachandra, K., Higgins, W., Lee, J., & Glick, A. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20472 · Cited by 57
Menthena, A., Koehler, C. I., Sandhu, J. S., Yovchev, M. I., Hurston, E., Shafritz, D. A., & Oertel, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.12.003 · Cited by 58
Sokolova, V., Fiorino, A., Zoni, E., Crippa, E., Reid, J. F., Gariboldi, M., & Pierotti, M. A. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25051 · Cited by 57
“…of growth promoting factors, such as the MYC proto-oncogene, (Mulder et al., 1988) and the consequent activation of cyclin-dependent kinase (CDK) inhibitors, such as CDKN1A (p21/WAF1) and CDKN2B (p15) (Hannon and Beach, 1994; Datto et al., 1995, Reynisdottir et al., 1995; Claassen and Hann, 2000).”
BackgroundMonsivais, D., Peng, J., Kang, Y., & Matzuk, M. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806838116 · Cited by 64
Jagirdar, J., Lee, T. C., Reibman, J., Gold, L. I., Aston, C., Bégin, R., & Rom, W. N. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s51197 · Cited by 57
New developments in melanoma genetics
Hayward, N. K. (2000) · Current Oncology Reports · doi:10.1007/s11912-000-0022-z · Cited by 64
Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer
Shin, J.-Y., Kim, H., Lee, K.-S., Kim, J., Park, J., Won, M., Chae, S.-W., Choi, Y., Choi, K., Park, Y.-E., et al. (2000) · Experimental & Molecular Medicine · doi:10.1038/emm.2000.14 · Cited by 60
Disruption of TGF-β growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization
Liu, X., Sun, Y., Ehrlich, M., Lu, T., Kloog, Y., Weinberg, R. A., Lodish, H. F., & Henis, Y. I. (2000) · Oncogene · doi:10.1038/sj.onc.1203991 · Cited by 66
Taipale, J., & Keski‐Oja, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4342 · Cited by 61
Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors
Han, Y., Nie, J., Wang, D. W., & Li, N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.931475 · Cited by 66
TGF β : A player on multiple fronts in the tumor microenvironment
Čaja, F., & Vannucci, L. E. (2014) · Journal of Immunotoxicology · doi:10.3109/1547691x.2014.945667 · Cited by 62
“Tumor suppression is promoted by repressing expression of c-Myc and cyklin-dependent kinase genes (CDKs) and by activating expression of CDK inhibitor genes p15, p21 and p27 (Datto et al., 1995; Hannon & Beach, 1994; Polyak et al., 1994).”
BackgroundSpontaneous arterial dissection: phenotype and molecular pathogenesis
Grond‐Ginsbach, C., Pjontek, R., Aksay, S. S., Hyhlik-Dürr, A., Böckler, D., & Groß-Weißmann, M.-L. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0276-z · Cited by 63
Гордеева, О. Ф. (2019) · Cells · doi:10.3390/cells8121500 · Cited by 60
Expression of cyclin-dependent kinase inhibitors during corneal wound repair
Zieske, J. D. (2000) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(99)00018-x · Cited by 57
TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study
Cox, D. G., Penney, K. L., Guo, Q., Hankinson, S. E., & Hunter, D. J. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-175 · Cited by 59
Wang, L., Zheng, S., Zheng, Z., & Casson, A. G. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i6.1156 · Cited by 59
Segaert, S., Garmyn, M., Degreef, H. J., & Bouillon, R. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12276488 · Cited by 57
p21: structure and functions associated with cyclin-CDK binding
Ball, K. L. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_10 · Cited by 62
Biochemical Characterization of p16 - and p18-containing Complexes in Human Cell Lines
Ragione, F. D., Russo, G. L., Oliva, A., Mercurio, C., Mastropietro, S., Pietra, V. D., & Zappia, V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.15942 · Cited by 56
Kfir, S., Ehrlich, M., Goldshmid-Shagal, A., Liu, X., Kloog, Y., & Henis, Y. I. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8239-8250.2005 · Cited by 57
Role of TGF-β in cancer and the potential for therapy and prevention
Kaklamani, V., & Pasche, B. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.4.649 · Cited by 67
Differential expression of transforming growth factors-β1, -β2 and -β3 in human colon carcinoma
Bellone, G., Carbone, A., Tibaudi, D., Mauri, F. A., Ferrero, I., Smirne, C., Suman, F. R., Rivetti, C., Migliaretti, G., Camandona, M., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00391-9 · Cited by 64
Cohen, T. V., Kosti, O., & Stewart, C. L. (2007) · Development · doi:10.1242/dev.02816 · Cited by 61
“…are direct transcriptional targets of TGF signaling 1389RESEARCH ARTICLEMAN1 is required for yolk-sac vasculogenesis D E V E LO P M E N T 1390 (Edwards et al., 1987; Hannon and Beach, 1994), and their increased expression suggests that TGF signaling is upregulated in the Man1GT/GT EB explants.”
BackgroundQin, J.-Z., Dummer, R., Burg, G., & Döbbeling, U. (1999) · Blood · doi:10.1182/blood.v93.1.260 · Cited by 59
Malumbres, M., de Castro, I. P., Santos, J., Piqueras, J. F., & Pellicer, À. (1999) · Oncogene · doi:10.1038/sj.onc.1202299 · Cited by 64
“The p15INK4b protein is an important mediator of the antiproliferative e ect of TGF-b (Hannon and Beach, 1994, Reynisdo ttir et al., 1995).”
BackgroundInfluentialMechanisms of TGF-β-Induced Cell Cycle Arrest
Hocevar, B. A., & Howe, P. H. (1998) · Mineral and Electrolyte Metabolism · doi:10.1159/000057360 · Cited by 62
Jagasia, A. A., Block, J. A., Qureshi, A., Díaz, M. O., Nobori, T., Gitelis, S., & Iyer, A. P. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04274-7 · Cited by 56
Serra, A., Gottardi, E. M., Ragione, F. D., Saglio, G. N., & Iolascon, A. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05358.x · Cited by 62
Genetic studies and molecular markers of bladder cancer
Cordon‐Cardo, C., Sheinfeld, J., & Dalbagni, G. M. (1997) · Seminars in Surgical Oncology · doi:10.1002/(sici)1098-2388(199709/10)13:5<342::aid-ssu8>3.0.co;2-d · Cited by 55
Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer
Leek, R. D., Hunt, N. C., Landers, R. J., Lewis, C. E., Royds, J. A., & Harris, A. L. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200003)190:4<430::aid-path538>3.0.co;2-6 · Cited by 322
Functional Analysis of a p21 Mutant (Arg94→ Trp) Identified in a Human Breast Carcinoma
Balbín, M., Hannon, G. J., Pendás, A. M., Ferrando, A. A., Vizoso, F., Fueyo, A., & López-Otín, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15782 · Cited by 55
Inhibitors of cyclin-dependent kinase and cancer
Biggs, J. R., & Kraft, A. S. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00198902 · Cited by 60
Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells
Fotedar, R., Brickner, H., Saadatmandi, N., Rousselle, T., Diederich, L., Munshi, A., Jung, B. H., Reed, J. C., & Fotedar, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202693 · Cited by 67
Long Noncoding RNAs in Lung Cancer
Roth, A., & Diederichs, S. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_444 · Cited by 53
“TGFβ1 was implicated in the upregulation of p15/CDKN2B and induction of subsequent cell cycle arrest (Hannon and Beach 1994; Robson et al. 1999).”
BackgroundIdentification of JTP‐70902, a p15INK4b‐inductive compound, as a novel MEK1/2 inhibitor
Yamaguchi, T., Yoshida, T., Kurachi, R., Kakegawa, J., Hori, Y., Nanayama, T., Hayakawa, K., Abe, H., Takagi, K., Matsuzaki, Y., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00604.x · Cited by 53
Bressler, J., Folsom, A. R., Couper, D. J., Volcik, K. A., & Boerwinkle, E. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp377 · Cited by 54
Wilson, C., Cajulis, E. E., Green, J. L., Olsen, T. M., Chung, Y.-A., Damore, M. A., Dering, J., Calzone, F. J., & Slamon, D. J. (2005) · Breast Cancer Research · doi:10.1186/bcr1343 · Cited by 68
Association of the 9p21.3 Locus With Risk of First-Ever Myocardial Infarction in Pakistanis
Saleheen, D., Alexander, M., Rasheed, A., Wormser, D., Soranzo, N., Hammond, N., Butterworth, A. S., Zaidi, M. A., Haycock, P., Bumpstead, S., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.197210 · Cited by 55
Sandhu, D. S., Shire, A. M., & Roberts, L. R. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01624.x · Cited by 59
Mutations of the Ki-ras, p53 andAPC genes in adenocarcinomas of the human small intestine
Arai, M., Shimizu, S., Imai, Y., Nakatsuru, Y., Oda, H., Oohara, T., & Ishikawa, T. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970207)70:4<461::aid-ijc14>3.0.co;2-i · Cited by 79
Kortlever, R. M., Nijwening, J. H., & Bernards, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803341200 · Cited by 54
TGF-β-dependent Cell Growth Arrest and Apoptosis
Lee, K.-Y., & Bae, S. (2002) · BMB Reports · doi:10.5483/bmbrep.2002.35.1.047 · Cited by 73
“TGF-β causes the up-regulation of p15INK4B mRNA, and increased binding of the gene product to cdk4 and cdk6 in epithelial cells (Hannon and Beach, 1994; Reynisdottir et al., 1995).”
BackgroundEwen, M. E., & Miller, S. J. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00010-d · Cited by 54
Park, T. J., Kim, H. S., Byun, K. H., Jang, J. J., Lee, Y. S., & Lim, I. K. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1022 · Cited by 54
Forus, A., Larramendy, M. L., Meza‐Zepeda, L. A., Bjerkehagen, B., Godager, L. H., Dahlberg, A. B., Sæter, G., Knuutila, S., & Myklebost, O. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00369-1 · Cited by 58
“Southern analyses cDNA probes for MDM2 [19] (Drs. D. L. George and B. Vogelstein), CDK4 cDNA was the clone pSS-CDK4-5 [20] (Dr. P. S. Meltzer), the HMGIC probe covered the 5 9 part of the gene including the complete protein coding region [21] (Dr. W. Van de Ven), cDNA probe for CDKN2B [22] (Dr. Beach).”
BackgroundCell cycle control of DNA replication
Fotedar, R., & Fotedar, A. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1809-9_6 · Cited by 59
Mishina, T., Dosaka‐Akita, H., Kinoshita, I., Hommura, F., Morikawa, T., Katoh, H., & Kawakami, Y. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690500 · Cited by 55
Key Effectors of Signal Transduction and G 1 Progression
Roussel, M. F. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60763-0 · Cited by 72
Hu, D. G., & Wan, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179952 · Cited by 55
Genome-Wide Association Studies for Atherosclerotic Vascular Disease and Its Risk Factors
Ding, K., & Kullo, I. J. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.816751 · Cited by 57
Girelli, D., Martinelli, N., Peyvandi, F., & Olivieri, O. (2009) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0029-1242721 · Cited by 57
Cortez, M. A., Ivan, C., Zhou, P., Wu, X., Ivan, M., & Calin, G. A. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380888-2.00004-2 · Cited by 59
“Besides controlling several pathways, TGFB1 prevents phosphorylation and inactivation of the tumor suppressor RB1 (Hannon and Beach, 1994).”
BackgroundCell cycle regulation: Repair and regeneration in acute renal failure
Price, P. M., Megyesi, J. K., & Safirstein, R. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_8.x · Cited by 59
Soto, J. L., Cabrera, C. M., Serrano, S., & López‐Nevot, M. Á. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-36 · Cited by 65
Comparative structure and characterization of a CDKN2 gene in a Xiphophorus fish melanoma model
Kazianis, S., Morizot, D. C., Coletta, L. D., Johnston, D., Woolcock, B. W., Vielkind, J., & Nairn, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202884 · Cited by 57
Histone deacetylases, transcriptional control, and cancer
Cress, W. D., & Seto, E. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200007)184:1<1::aid-jcp1>3.0.co;2-7 · Cited by 621
Vadiveloo, P. K., Filonzi, E. L., Stanton, H., & Hamilton, J. A. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00116-0 · Cited by 62
Schoecklmann, H. O., Rupprecht, H., Zauner, I., & Sterzel, R. B. (1997) · Kidney International · doi:10.1038/ki.1997.168 · Cited by 55
Biswas, T., Gu, X., Yang, J., Ellies, L. G., & Sun, L.-Z. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.12.018 · Cited by 52
“In addition to inducing cell cycle arrest, it also promotes apoptosis as well as cell senescence to maintain tissue homeostasis [3–6].”
Genetics of primary open angle glaucoma
Takamoto, M., & Araie, M. (2013) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-013-0286-0 · Cited by 57
Ellis, K. L., Pilbrow, A. P., Frampton, C. M., Doughty, R. N., WHALLEY, G. A., Ellis, C., Palmer, B. R., Skelton, L., Yandle, T. G., Palmer, S. C., et al. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.917443 · Cited by 52
Methylation and expression analysis of tumor suppressor genes p15 and p16 in benzene poisoning
Xing, C., Wang, Q., Li, B., Tian, H., Ni, Y., Yin, S., & Li, G. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.12.028 · Cited by 52
Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity
Hargadon, K. M. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5090076 · Cited by 62
Hardy, K., Mora, J. M., Dunlop, C. M., Carzaniga, R., Franks, S., & Fenwick, M. A. (2018) · Journal of Cell Science · doi:10.1242/jcs.218123 · Cited by 53
“…can regulate the expression of genes involved in the cell cycle, including Myc and the CDK inhibitors Cdkn1a, Cdkn1b and Cdkn2b (which encode p21CIP1, p27KIP1 and p15INK4B, respectively) (Chen et al., 2002; Frederick et al., 2004; Hannon and Beach, 1994; Lecanda et al., 2009; Seoane et al., 2001).”
BackgroundGiannouli, C., & Kletsas, D. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.11.002 · Cited by 57
L??pez-Guerrero, J. A., L??pez-Gin??s, C., Pell??n, A., Cardá, C., & Llombart‐Bosch, A. (2004) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200406000-00004 · Cited by 52
Kim, S. G., Kim, S. N., Jong, H.-S., Kim, N. K., Hong, S. H., Kim, S., & Bang, Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204203 · Cited by 59
p16INK4a Is Selectively Silenced in the Tumoral Progression of Mycosis Fungoides
Navas, I. C., Algara, P., Mateo, M. S., Martínez, P., García, C., Rodriguez, J. L., Vanaclocha, F., Barrientos, N., Iglesias, L., Sánchez, L., et al. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780405 · Cited by 55
“…been shown that p16INK4a and p14ARF, the two alternative products of the 9p21 region, play key roles in the maintenance of the Rb and p53 tumor suppressor pathways, respectively (Ching et al, 1998), whereas p15INK4b is a mediator of extracellular growth inhibition signals (Hannon and Beach, 1994).”
BackgroundInhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma
Wang, G. L., Lo, K. W., Tsang, K. S., Chung, N. Y. F., Tsang, Y. S., Cheung, S., Lee, J. C. K., & Huang, D. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690818 · Cited by 53
Kurita‐Ochiai, T., Ochiai, K., & Fukushima, K. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2587-2594.1998 · Cited by 52
González, M. V., Pello, M. F., López‐Larrea, C., Suarez, C. M., Menéndez, M., & Coto, E. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.6.509 · Cited by 55
Peterson, R. L., Bozza, M. M., & Dorner, A. J. (1996) · Europe PMC (PubMed Central) · Cited by 56
Alterations of CDKN2 (p16) in non‐small cell lung cancer
de Vos, S., Miller, C. W., Takeuchi, S., Gombart, A. F., Cho, S. K., & Koeffler, H. P. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870140303 · Cited by 57
Molecular Pathways for Cancer Angioprevention
Albini, A., Noonan, D. M., & Ferrari, N. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0069 · Cited by 55
Vagenas, K., Spyropoulos, C., Gavala, V., & Tsamandas, A. C. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2006.10.005 · Cited by 59
CAK-independent Activation of CDK6 by a Viral Cyclin
Kaldis, P., Ojala, P. M., Tong, L., Mäkelä, T. P., & Solomon, M. J. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.12.3987 · Cited by 58
“Members of the INK4 family are specific for CDK4 and CDK6 and include p15INK4b (Hannon and Beach, 1994), p16INK4a (Serrano et al., 1993), p18INK4c (Guan et al., 1994; Hirai et al., 1995), and p19INK4d (Chan et al., 1995; Hirai et al., 1995).”
BackgroundThomas, N. S. B., Pizzey, A. R., Tiwari, S., Williams, C. D., & Yang, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23659 · Cited by 53
Metadata
- Authors
- Hannon, G. J., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Hannon, Gregory J.
- Venue
- Nature
- Published
- 1994-09
- Volume
- 371
- Issue
- 6494
- Pages
- 257-261
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003907692
- Cited by
- 1,950
- References
- 29
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 26 · 2023: 26 · 2022: 22 · 2021: 30 · 2020: 18 · 2019: 42 · 2018: 29 · 2017: 24 · 2016: 37 · 2015: 48 · 2014: 37 · 2013: 44 · 2012: 54
- FWCI
- 51.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- CDKN2B, p16INK4, TGF-beta, cell cycle arrest, G1 phase, CDK4, CDK6, cyclin-dependent kinases, keratinocytes, 9p21, tumor suppressor, chromosome 9
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Cycle, Cell Line, Cloning, Molecular, Humans, Molecular Sequence Data, Proto-Oncogene Proteins, RNA, Messenger, Keratinocytes, Gene Expression, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p15, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.